We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Philips Healthcare

Operates in Diagnostic Imaging Systems, Patient Care and Clinical Informatics, Customer Services, and Home Healthcare... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Handheld Device Detects Heart Attacks

By LabMedica International staff writers
Posted on 15 Jun 2016
Print article
Image: The new Minicare I-20 handheld device detects proteins in the blood stream following a heart attack, providing results in just 10 minutes (Photo courtesy of Philips Healthcare).
Image: The new Minicare I-20 handheld device detects proteins in the blood stream following a heart attack, providing results in just 10 minutes (Photo courtesy of Philips Healthcare).
A new handheld blood test device is able to rapidly diagnosis heart attacks at the point of care, and has been specifically designed for use in emergency departments to dramatically reduce the time physicians take to diagnose heart attacks.

For patients presenting at emergency departments with chest pains, the device can be used to administer an immediate test, with results delivered while the patient is being assessed and a medical history taken and this reduces the time for the physician to decide on treatment.

The new system works by measuring the level of cardiac troponin I (cTnI), a protein that is excreted by the heart muscle into the blood following a heart attack. Current guidelines for the diagnosis of myocardial infarction require blood test results of the biomarker cardiac troponin for the 90% of patients who present at the emergency department (ED) with chest pain but are not diagnosed by an electrocardiogram (ECG). Physicians often have to wait up to six hours before it can be decided if they can safely discharge the patients or if they need to admit them into the hospital for further tests.

The use of device, called the Minicare I-20 cTnI (Philips Healthcare, Amsterdam. The Netherlands) supports a reduction of the diagnostic protocol by up to three hours. Each blood test has dedicated software and a single use, disposable cartridge containing the application-specific test. The technology has been designed to detect multiple target molecules at low concentrations within the same blood sample and to show the results on the device's display within minutes. For high-risk cardiac patients, such as those with Acute Coronary Syndrome, fast triage and rapid initiation of treatment are critical in order to improve patient outcomes and to save lives. Only 10% of chest pain patients can be diagnosed using an ECG. The rest need to rely on additional cardiac marker testing for the diagnosis of myocardial infarction.

Paul O Collinson MA MB BChir FRCPath MD FACB FRCP, the Consultant Chemical Pathologist and Professor of. Cardiovascular Biomarkers, at St. George's University Hospitals (London, UK,), said, “Blood samples are usually analyzed in the hospital laboratory, which can easily take more than an hour to get the result back to the ED physician. Point-of-care testing can significantly help to reduce the turnaround time.”

Related Links:
Philips Healthcare
St. George's University Hospitals

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.